Summary
Pfizer Inc. (PFE) filed an 8-K on December 14, 2020, to report the elimination of its Series A Convertible Perpetual Preferred Stock and Series B Junior Participating Redeemable Preferred Stock from its Restated Certificate of Incorporation. This action was taken by filing a Certificate of Elimination with the Delaware Secretary of State. Crucially, there were no outstanding shares of either preferred stock series as of the filing date. The company also filed an updated Restated Certificate of Incorporation to reflect these changes and consolidate previous amendments.
Key Highlights
- 1Elimination of Series A Convertible Perpetual Preferred Stock from corporate charter.
- 2Elimination of Series B Junior Participating Redeemable Preferred Stock from corporate charter.
- 3Filing of a Certificate of Elimination with the Delaware Secretary of State.
- 4Confirmation that no shares of Series A or Series B Preferred Stock were outstanding as of the filing date.
- 5Filing of an updated Restated Certificate of Incorporation to reflect the eliminations.
- 6Consolidation of prior amendments into the new Restated Certificate of Incorporation.
Frequently Asked Questions
The main purpose of this filing is to formally remove provisions related to two classes of preferred stock, Series A and Series B, from Pfizer's Certificate of Incorporation. This simplifies the company's corporate structure.
No, this filing does not directly impact existing common shareholders. It concerns the elimination of preferred stock series for which no shares were outstanding, thus having no effect on the rights or ownership of common stock.
Eliminating preferred stock classes with no outstanding shares is a common corporate housekeeping measure. It simplifies the company's charter, removes outdated provisions, and can streamline future corporate actions or restructurings.
This specific filing has no direct financial implications. Since no shares of the eliminated preferred stock were outstanding, there are no associated financial obligations or rights being terminated or changed for the company.